Page last updated: 2024-08-24

pobilukast and Coronary Disease

pobilukast has been researched along with Coronary Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Egan, JW; Griswold, DE; Hillegass, LM; Slivjak, MJ; Smith, EF	1

Other Studies

1 other study(ies) available for pobilukast and Coronary Disease

Article	Year
Inhibition of peptidoleukotriene responses does not moderate ischemic damage or neutrophil infiltration in myocardium following coronary artery occlusion with reperfusion. Progress in clinical and biological research, 1989, Volume: 301 Topics: Animals; Cell Movement; Coronary Disease; Dicarboxylic Acids; Leukotriene Antagonists; Leukotrienes; Male; Myocardial Reperfusion Injury; Neutrophils; Rats; Rats, Inbred Strains	1989

Article

Year

Inhibition of peptidoleukotriene responses does not moderate ischemic damage or neutrophil infiltration in myocardium following coronary artery occlusion with reperfusion.

Progress in clinical and biological research, 1989, Volume: 301

Topics: Animals; Cell Movement; Coronary Disease; Dicarboxylic Acids; Leukotriene Antagonists; Leukotrienes; Male; Myocardial Reperfusion Injury; Neutrophils; Rats; Rats, Inbred Strains

1989